Sandra Sanabria

Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers

Terence G. Hamill, Stephen M. Krause, Christine Ryan et al. · Synapse · 2005 · 152 citations

Kinetic Modeling of the Tau PET Tracer ¹⁸F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects

Olivier Barret, David Alagille, Sandra Sanabria et al. · Journal of Nuclear Medicine · 2016 · 73 citations · Full text

In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor α5 Subtype-Selective Inverse Agonist

John Atack, Karen Maubach, Keith A. Wafford et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 69 citations

Inverse agonist histamine H3 receptor PET tracers labelled with carbon‐11 or fluorine‐18

Terence G. Hamill, Nagaaki Sato, Makoto Jitsuoka et al. · Synapse · 2009 · 44 citations

Abstract LB-64: GDC-0032, a beta isoform-sparing PI3K inhibitor: Results of a first-in-human phase Ia dose escalation study.

Dejan Juric, Ian E. Krop, Ramesh K. Ramanathan et al. · Cancer Research · 2013 · 43 citations

Molecular Pharmacology, Oncology, Gdc-0032 Preclinical Data +15